Have You Ever Heard of Cannabigerol? It May Be the Future of Therapeutic Marijuana

  • This non-psychoactive cannabinoid, found in smaller quantities in most strains of cannabis, can help to enhance our health. Alleviating the discomfort of those suffering from overactive bladders, treating Huntington's disease, or slowing the spread of colon cancer are some of its possible applications that researchers are already studying.

In 1964 scientists discovered the existence of cannabigerol (CBG) as a component of hashish. A decade later they discovered that CBGA, an acid form of CBG, is transformed into THC, CBDA or CBA through the action of enzymes. Hence, CBGA is, in reality, the initial precursor of all cannabinoids, although very little remains on mature flowers.

The substance is found in most varieties of cannabis, in small amounts,generally less than 1%. It is a cannabinoid that is difficult to find, but one boasting great therapeutic potential.

We recently told you about a study that had demonstrated how CBG could help ease the suffering of people with overactive bladders. This is not the only benefit that this substance could have for human health: researchers have confirmed that CBG also has neuroprotective effects on mice with Huntington's disease, a serious neurological disorder that is hereditary and degenerative.

Cannabigerol was also effective at slowing the progression of colon cancer in mice,which would represent a major advance in the fight against this disease. CBG could also be used as an antidepressant, analgesic and even as a potential treatment for psoriasis. Researchers are studying a broad range of benefits for our health.

However, to take advantage of marijuana’s positive effects it will be necessary to cultivate strains richer in cannabigerol, or extract it during the flowering stage. So, now you know: it is not just THC and CBD that can help in the fight against cancer. This lesser-known cannabinoid can also contribute to our well-being.

15/06/2016

Comments from our readers

There are no comments yet. Would you like to be the first?

Leave a comment!

Contact us

x
Contact us